202
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Illness Acceptance as the Measure of the Quality of Life in Moderate Psoriasis

, , , & ORCID Icon
Pages 1139-1147 | Published online: 28 Aug 2021

References

  • Ferreira BI, Abreu JL, Reis JP, et al. Psoriasis and associated psychiatric disorders a systematic review on etiopathogenesis and clinical correlation. J Clinic Aesthet Dermatol. 2016;9(6):36–43.
  • Krueger G, Koo J, Lebwohl M, et al. The impact of psoriasis on quality of life: results of a 1998 national psoriasis foundation patient- membership survey. Arch Dermatol. 2001;137(3):280–284.
  • Langley RGB, Krueger GG, Griffiths CEM. Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis. 2005;64(Suppl2):ii18–ii23. doi:10.1136/ard.2004.033217
  • Christophers E. Psoriasis –epidemiology and clinical spectrum. Clin Exp Dermatol. 2001;26(4):314–320. doi:10.1046/j.1365-2230.2001.00832.x
  • Scala E, Megna M, Amerio P, et al. Patients’ demographic and socioeconomic characteristics influence the therapeutic decision-making process in psoriasis. PLoS One. 2020;15(8):e0237267. doi:10.1371/journal.pone.0237267
  • Gelfand JM, Feldman SR, Stern RS, et al. Determinants of quality of life patients with psoriasis: a study from the U.S. population. J Am Acad Dermatol. 2004;51(5):704–708. doi:10.1016/j.jaad.2004.04.014
  • Miniszewska J, Juczyński Z, Ograczyk A, et al. Health-related quality of life in psoriasis: important role of personal resources. Acta Derm Venereol. 2013;93(5):551–556. doi:10.2340/00015555-1530
  • Bowling A, Farquhar M, Browne P. Life satisfaction and associations with social network and support variables in three samples of elderly people. Int J Geriatr Psychiatr. 1991;6(8):549–566. doi:10.1002/gps.930060803
  • Zalewska A, Miniszewska J, Chodkiewicz J, et al. Acceptance of chronic illness in psoriasis vulgaris patients. J Eur Acad Dermat Venereol. 2007;21(2):235–242. doi:10.1111/j.1468-3083.2006.01912.x
  • Basińska MA, Woźniewicz A. Emotional intelligence in psoriasis patients as a determinant of acceptance of illness. Rev Dermat. 2012;99(3):202–209.
  • Ginsburg IH. Psychological and psychophysiological aspects of psoriasis. Derm Clin. 1995;13(4):793–804. doi:10.1016/S0733-8635(18)30043-3
  • Zachariae R, Oster H, Bjerring P, et al. Effects of psychologic intervention on psoriasis: a preliminary report. J Am Acad Dermatol. 1996;34(6):1008–1015. doi:10.1016/S0190-9622(96)90280-7
  • Juczyński Z. Narzędzia Pomiaru w Promocji I Psychologii Zdrowia[Measurement Tools in Health Promotion and Psychology]. Warszawa: Pracownia Testów Psychologicznych Polskiego Towarzystwa Psychologicznego; 2001:168–172. Polish.
  • Szepietowski J, Salomon J, Finlay AY, et al. Dermatology Life Quality Index (DLQI): polish version. Dermatol Klin. 2004;6:63–70.
  • Gupta MA. Psychosocial aspects of common skin disease. Can Fam Physician. 2002;48:712–716.
  • Gupta MA, Gupta AK. Psychiatric and psychological comorbidity in patients with dermatologic disorders: epidemiology and management. Am J Clin Dermatol. 2003;4(12):833–842. doi:10.2165/00128071-200304120-00003
  • Picardi A, Abeni D, Melchi CF, et al. Psychiatric morbidity in dermatological outpatients: an issue to be recognized. Br J Dermatol. 2000;143(5):983–991. doi:10.1046/j.1365-2133.2000.03831.x
  • Picardi A, Amerio P, Baliva G, et al. Recognition of depressive and anxiety disorders in dermatological outpatients. Acta Derm Venereol. 2004;84(3):213–217. doi:10.1080/00015550410025264
  • Gieler U, Kupfer J, Niemeier V, et al. Psyche and skin: what’s new? J Eur Acad Dermatol Venereol. 2003;17(2):128–130. doi:10.1046/j.1468-3083.2003.00618.x
  • de Korte J, Sprangers MAG, Mombers FMC, et al. Quality of life in patients with psoriasis: a systematic literature review. J Investig Dermatol Symp Proc. 2004;9(2):140–147. doi:10.1046/j.1087-0024.2003.09110.x
  • Finlay A. Psoriasis from the patient’s point of view. Arch Dermatol. 2001;137(3):352–353.
  • Heydendael VM, de Borgie CA, Spuls PI, et al. The burden of psoriasis is not determined by disease severity only. J Investig Dermatol Symp Proc. 2004;9(2):131–135. doi:10.1111/j.1087-0024.2004.09115.x
  • Vardy D, Besser A, Amir M, et al. Experiences of stigmatization play a role in mediating the impact of disease severity on quality of life in psoriasis patients. Br J Dermatol. 2002;147(4):736–742. doi:10.1046/j.1365-2133.2002.04899.x
  • Gupta MA, Gupta AK. A practical approach to the assessment of psychosocial and psychiatric comorbidity in the dermatology patient. Clin Dermatol. 2013;31(1):57–61. doi:10.1016/j.clindermatol.2011.11.007
  • Patruno C, Ayala F, Megna M, et al. Patient-physician relationship in patients with psoriasis. Indian J Dermatol Venereol Leprol. 2012;78(2):228. doi:10.4103/0378-6323.93657
  • Kostyła M, Tabała K, Kocur J. Illness acceptance degree versus intensity of psychopathological symptoms in patients with psoriasis. Postepy Dermatol Alergol. 2013;30(3):134–139. doi:10.5114/pdia.2013.35613
  • Kowalewska B, Cybulski M, Jankowiak B, et al. Acceptance of illness, satisfaction with life, sense of stigmatization, and quality of life among people with psoriasis: a cross-sectional study. Dermatol Ther (Heidelb). 2020;10(3):413–430. doi:10.1007/s13555-020-00368-w
  • Zielińska-Więczkowska H, Pietrzak N. Akceptacja choroby i jej związek z jakością życia pacjentów z łuszczycą [Acceptance of illness and its correlation with the quality of life in patients with psoriasis]. Med Rodz. 2018;21(1):3–9. Polish.
  • Harrison T, Stuifbergen A, Adachi E, et al. Marriage, impairment and acceptance in persons with multiple sclerosis. West J Nurs Res. 2004;26(3):266–285. doi:10.1177/0193945903260188
  • Hawro T, Janusz I, Miniszewska J, et al. Jakość życia i stygmatyzacja a nasilenie zmian skórnych i świądu u osób chorych na łuszczycę [Quality of life and stigmatization and the severity of skin lesions and itching in patients with psoriasis]. In: Rzepa T, Szepietowski J, Żaba R, editors. Psychologiczne I Medyczne Aspekty Chorób Skóry[Psychological and medical aspects of skin diseases]. Cornetis: Wrocław; 2011:42–51. Polish.
  • van Beugen S, van Middendorp H, Ferwerda M, et al. Predictors of perceived stigmatization in patients with psoriasis. Br J Dermatol. 2017;176(3):687–694. doi:10.1111/bjd.14875
  • Ograczyk A, Miniszewska J, Kępska A, et al. Itch, disease coping strategies and quality of life in psoriasis patients. Postep Derm Alergol. 2014;31(5):299–304.
  • Sampogna F, Sera F, Mazzotti E, et al. Performance of the self-administered psoriasis area and severity index in evaluating clinical and sociodemographic subgroups of patients with psoriasis. Arch Dermatol. 2003;139(3):353–358. doi:10.1001/archderm.139.3.353
  • Miniszewska J, Adamska M. Przekonania na temat zdrowia i choroby a akceptacja ograniczeń wynikających z przewlekłej choroby somatycznej na przykładzie osób z łuszczycą. Psychiatr Psychol Klin. 2014;14(3):202–212. doi:10.15557/PiPK.2014.0029
  • Zięciak T, Rzepa T, Król J, et al. Feelings of stigmatization and depressive symptoms in psoriasis patients. Psychiatr Pol. 2017;51(6):1153–1163. doi:10.12740/PP/68848
  • Lu Y, Duller P, van der Valk PGM, et al. Helplessness as predictor of perceived stigmatization in patients with psoriasis and atopic dermatitis. Dermatol Psychosomatik. 2003;4(3):146–150. doi:10.1159/000073991
  • Zachariae R, Zachariae H, Ibsen HHW, et al. Psychological symptoms and quality of life of dermatology outpatients and hospitalized dermatology patients. Acta Derm Venereol. 2004;84(3):205–212. doi:10.1080/00015550410023284
  • Fortune DG, Main CJ, O’Sullivan TM, et al. Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress. Br J Dermatol. 1997;137(5):755–760. doi:10.1111/j.1365-2133.1997.tb01113.x
  • Orion E, Wolf R. Psychologic consequences of facial dermatoses. Clin Dermatol. 2014;32(6):767–771. doi:10.1016/j.clindermatol.2014.02.016
  • Hrehorów E, Salomon E, Matusiak Ł, et al. Patients with psoriasis feel stigmatized. Acta Derm Venereol. 2012;92(1):67–72. doi:10.2340/00015555-1193
  • Orzechowska A, Talarowska M, Wysokiński A, et al. Wybrane czynniki psychologiczne w łuszczycy i trądziku różowatym. Dermatol Klin. 2009;11(1):17–20.
  • Russo PAJ, Ilchef R, Cooper AJ. Psychiatric morbidity in psoriasis: a review. Australas J Dermatol. 2004;45(30):155–161. doi:10.1111/j.1440-0960.2004.00078.x
  • Devrimci-Ozguven H, Kundakci TN, Kumbasar H, et al. The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients. J Eur Acad Dermatol Venereol. 2000;14(4):267–271. doi:10.1046/j.1468-3083.2000.00085.x
  • Karia SB, De Sousa A, Shah N, et al. Psychiatric morbidity and quality of life in skin diseases: a comparison of alopecia areata and psoriasis. Ind Psychiatry J. 2015;24(2):125–128. doi:10.4103/0972-6748.181724
  • Ginsburg IH, Link BG. Feelings of stigmatization in patients with psoriasis. J Am Acad Dermatol. 1989;20(1):53–63. doi:10.1016/S0190-9622(89)70007-4
  • Hrehorów E, Reich A, Szepietowski J. Jakość życia chorych na łuszczycę: zależność od świądu, stresu i objawów depresyjnych [Quality of life in patients with psoriasis: dependence on pruritus, stress and depressive symptoms]. Dermatol Klin. 2007;9(1):19–23. Polish.
  • Verhoeven EWM, Kraaimaat FW, van de Kerkhof PCM, et al. Prevalence of physical symptoms of itch, pain and fatigue in patients with skin diseases in general practice. Br J Dermatol. 2007;156(6):1346–1349. doi:10.1111/j.1365-2133.2007.07916.x